Showing results (321-330 of 1,193) with videos related to

Sort By:
Pageof 120
Cancer Treatment Reports|May 1, 1977
Phase I-II evaluation of cyclocytidineM A Burgess, G P Bodey, R A Minow, et al.
American Journal of Clinical Oncology|December 1, 1982
AZQ therapy in patients with disseminated malignant melanomaB S Yap, A Y Bedikian, M A Burgess, et al.
Archives of Internal Medicine|May 24, 1993
Ciprofloxacin-induced nephrotoxicity in patients with cancerW K Lo, K V Rolston, E B Rubenstein, et al.
Cancer|April 1, 1977
Hypocalcemia with hypoparathyroidism and renal tubular dysfunction associated with aminoglycoside therapyM J Keating, M R Sethi, G P Bodey, et al.
American Journal of Clinical Oncology|April 1, 1983
A comparative study of oral tegafur and intravenous 5-fluorouracil in patients with metastatic colorectal cancerA Y Bedikian, J Stroehlein, J Korinek, et al.
AJR. American Journal of Roentgenology|December 1, 1976
Radiologic features of gram-negative pneumonias in the neutropenic patientJ Zornoza, A M Goldman, S Wallace, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1986
In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patientsK V Rolston, M E Alvarez, K C Hsu, et al.
Cancer|October 15, 1982
The natural history of resectable metastatic melanoma (Stage IVA melanoma)L G Feun, J Gutterman, M A Burgess, et al.
The American Journal of Medicine|February 1, 1988
Central nervous system histoplasmosis. An unappreciated complication of the acquired immunodeficiency syndromeE Anaissie, V Fainstein, T Samo, et al.
The American Journal of Medicine|August 1, 1987
Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous cathetersJ F Hoy, K V Rolston, R L Hopfer, et al.
Pageof 120